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Abstract
With the emergence of precision medicine, estimating optimal individualized decision rules
(IDRs) has attracted tremendous attention in many scientific areas. Most existing literature
has focused on finding optimal IDRs that can maximize the expected outcome for each individ-
ual. Motivated by complex individualized decision making procedures and popular conditional
value at risk (CVaR) measures, we propose a new robust criterion to estimate optimal IDRs in
order to control the average lower tail of the subjects’ outcomes. In addition to improving the
individualized expected outcome, our proposed criterion takes risks into consideration, and thus
the resulting IDRs can prevent adverse events. The optimal IDR under our criterion can be
interpreted as the decision rule that maximizes the “worst-case” scenario of the individualized
outcome when the underlying distribution is perturbed within a constrained set. An efficient
non-convex optimization algorithm is proposed with convergence guarantees. We investigate
theoretical properties for our estimated optimal IDRs under the proposed criterion such as con-
sistency and finite sample error bounds. Simulation studies and a real data application are used
to further demonstrate the robust performance of our method.
Keywords: Conditional Value at Risk; Individualized decision rules; Non-convex optimiza-
tion; Robustness; Tail controls
1 Introduction
Decision making is a long standing research problem in many scientific areas, ranging from
engineering, management science to statistics. In the era of big data, the traditional “one fits
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all” decision rules are no longer ideal in many applications due to data heterogeneity. A decision
rule that works for certain subjects may not necessarily work for others. Motivated by this, it is
desirable to make individualized decision rules (IDRs) that map from individual characteristics into
available decision assignments. Developing effective IDRs has a wide range of applications. For
example, a credit card company hopes to send a special offer for each targeted customer tailoring
to his/her personal needs. An epidemiologist needs to decide whether to deliver a vaccine plan to
a specific region in order to prevent the spread of diseases. In medical applications, IDRs can be
developed for better prevention and treatment methods that are tailored to each individual patient.
This is known as precision, or personalized, medicine.
Most existing methods in the literature, from data analytic perspective, are focused on estimat-
ing the optimal IDR that can maximize the expected outcome or minimize the expected loss for
each subject, such as Qian and Murphy (2011)and Manski (2004). For example, we may want to
learn an IDR d that maps a subject’s covariate X ∈ X into a binary decision space A = {1,−1},
i.e., d : X → A, in order to maximize the expectation of R(d) or a utility function u of R(d). Here
R(d) is the random outcome under IDR d, which will be formally defined in the next section. Then
the problem can be mathematically formulated as the following optimization problem:
max
d∈D
E[R(d)], (1)
where D is a structural class of IDRs specified by practitioners, such as decision trees. If the utility
function u is used, then one could replace the objective function in (1) with E[u(R(d))]. The
equivalent form of Problem (1) is
max
t∈R,d∈D
t
subject to t ≤ E[R(d)],
(2)
by using a hypographical representation (Rockafellar and Wets (2009)).
According to (2), it may be reasonable to restrict the expected outcome larger than some
threshold when stochastic ups and downs of outcome R(d) can be safely averaged out. Then by
implementing the IDR obtained by (2), we can guarantee on average the outcome will be better than
some threshold t. However, in practice, practitioners usually want to have a safe margin to protect
against undesired outcomes, especially when the lower tails of the outcome are more important.
For instance, in reliability engineering (Rockafellar and Royset (2010)), people are often interested
in controlling the failure probability of some designed systems or structures such as buildings and
bridges, instead of expected failure time. Here the selection of designs can be interpreted as IDRs
based on environmental conditions, existing materials, etc. In precision medicine, sometimes the
gain in the expected outcome may be very little by comparing two treatments while the tail of
the potential outcome distribution is of direct interest (Wang et al. (2018)). Suppose two drugs
are used to improve CD4 T cell amount of AIDS patients. Since normal range of CD4 cells is
500-1500, then in practice the event of a certain subject {Ri(d) = 600} may be treated as good as
the event of {Ri(d) = 800}. In contrast, the event {Ri(d) = 50} may be considered much worse
2
than {Ri(d) = 400}. Hence only using (2) to search for best IDRs may be insufficient when the tails
are important or the variability of the outcomes needs to be controlled. For further illustrations,
we consider the following toy example.
Toy Example: Figure 1 plots the conditional density of a random outcome R under two treat-
ments 1 and −1, given the patient’s gender, i.e., male or female. Each curve corresponds to a
different Gaussian density curve. If we only consider the optimal IDR that maximizes the expected
outcome, treatment 1 is more suitable for female while treatment −1 is better for male. However,
the gain is quite little since the mean difference is only 0.1, and thus it is hard to distinguish
between these two treatments given the gender information. However, if we consider the lower
tails of outcomes caused by each treatment, in order to protect each person from risky scenarios,
then treatment 1 is more favorable than treatment −1 for male, and similarly, treatment −1 is
more preferable than treatment 1 for female. This treatment rule may be more reasonable than the
previous one because we do not want to assign patients unstable treatments with potentially high
risk. We will revisit this example in our numerical studies in Section 5 for further illustrations.
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Figure 1: Plots of a motivating example. The dash and solid lines in the left plot show the
probability densities of N (−0.1, 0.5) and N (0, 1) respectively. The dash and solid lines in the
right plot correspond to the probability densities of N (0, 1) and N (−0.1, 0.5) respectively. In this
example, male is more preferable to treatment 1, while female is more preferable to treatment −1.
As we can see from Figure 1, due to the complicated decision making procedure, only targeting
on the expected outcome of each subject may not be sufficient. Risk control is necessary to prevent
adverse events, i.e., the lower tails of outcomes. In this paper, motivated by the conditional value
at risk (CVaR) used extensively in finance and risk management (Rockafellar and Uryasev (2000)),
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we propose a new criterion that considers average lower tails of outcome to evaluate IDRs. The
resulting IDR under our proposed criterion can optimize the outcome of each individual and provide
a safe margin against adverse events jointly.
1.1 Related Literature
There is an increasing body of literature in learning optimal IDR under the framework of (1).
The literature spans across various fields such as statistics, economics and machine learning. In
the statistics literature, most existing methods can be roughly divided into two categories: model
based methods and direct search methods. Q-learning (Watkins (1989), Murphy (2005), Schulte
et al. (2014)) and A-learning (Murphy (2003), Robins (2004)) are two representative model based
methods. Other variants include Fan et al. (2017), Gunter et al. (2011), etc. For direct search
methods, by viewing IDR problems as a weighted classification problem, Zhao et al. (2012) proposed
to use the weighted support vector machine method to estimate the optimal IDR. Following that,
various types of machine learning methods were proposed, such as Liu et al. (2018), Zhou et al.
(2017), Zhao et al. (2015), Cui et al. (2017), Tao and Wang (2017), Laber and Zhao (2015), Zhang
et al. (2015), Chen et al. (2018), etc. In addition, Tian et al. (2014), Qi and Liu (2018) and Qi
et al. (2019) proposed to use regression methods to directly estimate the optimal IDR. Recently,
Wang et al. (2018) proposed to use the quantile of R(d) as a criterion to search for best IDRs,
which is closely related to this paper. Their method can help to obtain robust optimal IDRs by
controlling the lower quantile. However, it can be instable when the potential outcome distribution
is discrete. More importantly, as we mentioned in the example of CD4 T cells, lower tails of the
outcome should be treated differently: if both {Ri(d) = 50} and {Ri(d) = 400} are below the 25%
quantile, the first event should be considered much worse than the latter one. More discussions on
the difference between our criterion and the quantile one can be found in Section 2.
In the econometrics literature, Manski (2004) provided a comprehensive regret analysis of es-
timating optimal IDRs with a link to statistical decision theory (Savage (1951)). Later on, exact
finite sample regret analysis was established by Stoye (2009) and Tetenov (2012). Under smooth
parametric and semi-parametric settings, Hirano and Porter (2009) investigated asymptotic opti-
mality and large sample properties of optimal IDRs. Other related work includes Chamberlain
(2011); Bhattacharya and Dupas (2012); Kasy (2016). Recently, Kitagawa and Tetenov (2018) and
Athey and Wager (2017) established rate-optimal regret bounds for learning optimal IDRs. All of
these existing developments are based on expected outcome or expected utility. We also note that
Dehejia (2008) studied the risk aversion of treatment effect evaluation by using the mean-variance
trade off criterion.
We would like to point out the increasing literature of learning optimal IDRs in machine learning
community, which is often referred as batch learning from bandit feedback. In particular, Beygelz-
imer and Langford (2009) formulated the IDR problem as a weighted supervised learning problem.
Dud´ık et al. (2011) developed doubly robust estimators for IDR evaluations and used machine
learning algorithms to search optimal IDRs. The follow up empirical applications can be found in
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Li et al. (2010, 2011, 2015). Swaminathan and Joachims (2015) proposed to use variance regular-
ized empirical risk approximation to Problem (1) in order to improve robustness and generalization
performance of learning optimal IDRs. Recently, Kallus (2018) made use of matching techniques in
causal inference to efficiently evaluate IDR and leveraged bi-level optimization techniques to search
for the best IDRs, which improves the empirical performances. These existing methods do not
consider risk control for estimation of IDRs. Finally, we note that in the reinforcement learning
literature, CVaR has been used as constraints in Markov decision processes such as Tamar et al.
(2015) and Chow et al. (2017).
1.2 Main Contributions and Outline
The main contributions of this paper can be summarized as follows. We leverage the CVaR
criterion and propose a robust criterion to directly estimate the optimal IDR that can maximize
the expected outcome while simultaneously controlling the average lower tails of the outcome. We
discuss several important properties of our criterion and its practical usage by providing safety pro-
tection for implementing optimal IDRs. An efficient non-convex optimization algorithm is proposed
to compute the solutions with a convergence guarantee. We establish several important theoretical
properties of our estimator under the proposed criterion similar to the regret analysis in Zhao et al.
(2012); Zhou et al. (2017); Kitagawa and Tetenov (2018); Athey and Wager (2017).
The remainder of this paper is organized as follows. In Section 2, supplementing the previous
value function framework, we introduce a new criterion to estimate the optimal IDR by using the
concept of CVaR in risk management. We present several properties of our proposed criterion.
In Section 3, we discuss our statistical estimation procedure to compute optimal IDRs under our
proposed criterion. An efficient non-convex optimization algorithm is presented by using some
recent developments in difference of convex algorithms (DCA). In Section 4, we establish several
important theoretical properties of our method based on statistical learning theory. We demonstrate
our method via extensive simulation studies and a data application in Sections 5. In Section 6,
we discuss several extensions of our proposed criterion from the perspectives of algorithm and
modeling. Some technical results are provided in the supplementary materials.
2 Robust Criteria to Estimate Optimal IDRs
2.1 Notation and Basic Settings
We discuss our IDR problem under the Neyman-Rubin causal framework (Rubin (1974)). Sup-
pose there is a random sample of size n from a given population. For each subject in this sample, we
observe covariate information Xi ∈ X , where X ⊆ Rp, for i = 1, · · · , n. Each subject is associated
with a pair of potential outcomes, (Ri(1), Ri(−1)), which are scalars. We can only observe either
Ri(1) or Ri(−1) based on which treatment has been assigned. Here Ai ∈ A = {1,−1} denotes the
treatment that i-th subject has received. Therefore, for each subject, we observe (Xi, Ai, Ri), where
Ri = Ri(Ai). By doing that, we assume the stable unit treatment value assumption (SUTVA) (Ru-
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bin (1990)). We define pi(A|X) to be the probability of a subject being assigned treatment A given
the covariates and denote P d as the probability measure when treatment follows the decision rule
d. In addition, throughout this paper, we use the following two standard assumptions under the
potential outcome framework.
Assumption 2.1. (Ignorable assignment mechanism). Ri(1), Ri(−1) ⊥ Ai |Xi, where ⊥ denotes
independence.
Assumption 2.2. (Strong overlap assumption). c ≤ pi(A|X) ≤ (1− c) for some c > 0.
For simplicity, we assume the random outcome R has a bounded support. Without loss of
generality, we assume that the larger R indicates the better condition a subject is in. Throughout
this paper, we consider a randomized experiment so the propensity score pi(A|X) is known. For
observational studies, the proposed method can be applied as well by estimating the propensity score
using various methods such as the logistic regression. An IDR d is defined as a measurable function
mapping from the covariate space X into the treatment space A. We also let Lr(T ,F1, P d) be the
space of all measurable functions such that
∫
T∈T |f(T )|rdP d < ∞, where F1 is the corresponding
σ-field generated by T := X ×A× R.
2.2 Expected Value Function Framework
Before introducing our new criterion and methods, we first present the existing value function
framework used by most existing methods, such as Manski (2004) and Qian and Murphy (2011).
The value function is defined as
V (d) = E[R(d)] = EX [E[R(d)|X]]
= EX [E[R(d)|X, A = d(X)]]
= EX [E[R|X, A = d(X)]]
= E
[
RI(A = d(X))
pi(A|X)
]
,
(3)
where the second line is based on Assumption 2.1, the third line is based on the SUTVA assumption
in Section 2.1 and the last line relies on Assumption 2.2. Based on this value function, an optimal
IDR d0 is defined as
d0 ∈ argmaxdV (d). (4)
Note that
V (d) = E[E[R|X, A = 1]I(d(X) = 1) +E[R|X, A = −1]I(d(X) = −1)]
= E[(E[R|X, A = 1]−E[R|X, A = −1])I(d(X) = 1)] +E[E[R|X, A = −1]],
and then as a result,
d0(X) ∈ argmaxa∈AE[R|X, A = a], (5)
almost surely. It is observed that under the value function framework, the optimal IDR is to select
the treatment with the largest expected outcome among all treatments for each patient.
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Despite the progress of developing optimal IDRs in the intersection of statistics, econometrics
and machine learning, only focusing on obtaining the largest expected outcome for each individual
can be too restrictive and sometimes may not be even safe. For example, doctors may want to
know whether a treatment does the best to improve the worst scenario, in particular for a high
risk patient. Without such a risk consideration, this may lead to potentially severe events, such
as exacerbation or hospitalization in practice. Similar concerns may happen in the credit card
company, where the “best” policy should not only improve the average profit for the company,
but also reduce the chance of incurring a heavy loss. This motivates us to control risk exposure
associated with the corresponding decision rules, in addition to maximizing the expected outcome
of each individual.
2.3 Conditional Value at Risk
It is natural to consider some robust metrics such as quantiles of R given X and A to measure
the effect of a treatment (Wang et al. (2018)). The corresponding optimal IDR d˜ under the quantile
can be defined as
d˜ ∈ argmaxdQγ(R(d)), (6)
where Qγ(R(d)) = inf{α : P [R(d) < α] ≥ 1− γ} and γ ∈ (0, 1), i.e., γ-quantile of R(d). Analogous
to Problems (1) and (2), an equivalent form of Problem (6) can be stated as follows:
max
t∈R,d
t
subject to t ≤ Qγ(R(d)).
(7)
Based on the above representation, roughly speaking, the constraint set {t ≤ Qγ(R(d))} implies
that (1 − γ) × 100% of the population under the given IDR are controlled to be greater than a
certain threshold t. Thus under the quantile criterion, one can obtain a robust IDR that can
improve almost (1− γ)× 100% of the population in some extent.
There are several potential drawbacks of using quantile in IDR problems. First of all, using
the quantile criterion treats all the outcomes lower than Qγ(R(d)) as the same. However, as we
pointed out in one of our early examples, the CD4 T cell {Ri(d) = 400} below the normal level
is considered to be much better than {Ri(d) = 50}, therefore they should be treated differently
in practice. Secondly, Qγ(R(d)) is generally not continuous in γ, which may cause instability.
For instance, if the outcome distribution is discrete and a small change happens in γ, the resulting
optimal d˜ may change significantly. Lastly, from the computational perspective, the quantile makes
the optimization Problem (6) hard to solve while Nouiehed et al. (2017) recently has proved that
quantile of random functional can be represented as a difference-of-convex function.
In order to address the drawbacks of using quantiles, also known as Value-at-Risk, we propose
to use conditional value at risk (CVaR), also known as expected tail loss, which was proposed by
Artzner et al. (1999) in risk management. Consider a continuous random variable Y . Then the
original γ-CVaR of Y is defined as
S(FY ) :=
1
γ
E[Y I(Y ≤ Qγ(FY ))], (8)
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where FY is the corresponding probability distribution of Y . Based on this definition, the γ-CVaR
can be interpreted as a truncated mean lower than the γ-quantile of Y . For the general setting,
instead of assuming a continuous distribution of Y , γ-CVaR is defined as an optimal value of a
concave maximization problem by the celebrated work of Rockafellar and Uryasev (2000), which is
defined as follows:
S(FY ) := sup
α∈R
{
α− 1
γ
E[(α− Y )+]
}
, (9)
where [t]+ = max(0, t). The leftmost of the optimal solution set to (9) is Qγ(FY ) (Rockafellar and
Uryasev, 2000, Theorem 1). Then one can see that the definition in (9) is equivalent to (8) when
the outcome distribution of Y is continuous. As a remark, we note that Y is often referred to as a
loss in the finance literature. However, here we call Y an outcome in order to be consistent with
our problem setting.
We would like to point out that γ-CVaR has several nice properties discussed by Artzner et al.
(1999) and it is in general preferable to quantile measure (Sarykalin et al. (2008)). In particular,
based on the interpretation of (8), γ-CVaR considers average outcomes lower than γ-quantile,
which treats lower tails of outcome differently. This exactly satisfies our purpose. The concave
maximization formulation in (9) demonstrates the continuity of γ-CVaR with respect to γ, which
provides more stability measure compared with the quantile criterion. Furthermore, γ-CVaR is
considered to be more computationally efficient than the quantile criterion because of the concave
maximization formulation. In addition, Pflug (2000) or Rockafellar and Uryasev (2002) showed that
S(FY ) ≤ Qγ(FY ), which is more conservative than γ-quantile. This implies that larger γ-CVaR of a
random outcome indicates larger corresponding γ-quantile. Clearly the reverse inequality does not
necessarily hold. These nice properties motivate us to use it in the IDR problems. For the related
theoretical discussion about CVaR, we refer to Rockafellar and Uryasev (2002) and the references
therein.
2.4 A New Robust Criterion for IDR Problems
In this subsection, we borrow the concept of CVaR in order to conduct risk control to obtain
a robust optimal IDR that can improve the lower tails of outcomes. Specifically, we define the
following decision-rule based CVaR criterion as
M0(d) := sup
α∈R
{
α− 1
γ
E[(α−R(d))+]
}
. (10)
Note that the difference between the criterion 10 and the original CVaR is to let the outcome
depend on IDR d. Given the coherence property of CVaR in Artzner et al. (1999), we have the
corresponding properties of M0(d).
Proposition 2.1. The following properties of M0(d) hold.
(a) If R is shifted by a constant c, then M0(d) is also shifted by the same constant c;
(b) If R is multiplied by a positive constant c, then the corresponding M0(d) is also multiplied by
the same constant c;
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(b) Given two IDRs d1 and d2, if R(d1) ≤ R(d2), a.s., then
M0(d1) ≤M0(d2); (11)
(d) Given IDR d, M0(d) ≤ min{V (d), Qγ(R(d))}.
In addition, if outcome R = c, a.s.,, then M0(d) = c.
Remark 2.1. The above Proposition (2.1) justifies the use of M0(d). In particular, (a) and (b)
demonstrate that M0(d) is not affected by a constant shift or multiplication. (c) implies that if
one IDR is strictly better than the other, M0(d) has the same preference. The last property (d)
indicates that M0(d) is more conservative than the expected outcome and the quantile criterion
when evaluating IDR d.
If the distribution of R(d) is continuous, then we could rewrite (10) as
M0(d) =
Ed[RI(R ≤ Qγ(R(d)))]
γ
. (12)
Note that
P (R(d) < α) = E
[
I(A = d(X))
pi(A|X) I(R < α)
]
= E[
∑
a∈A
I(d(X) = a)P (R < α|X, A = a)]
= E[P (R < α|X, A = d(X))].
(13)
Then Qγ(R(d)) can be further expressed as
Qγ(R(d)) = inf {α |E[P (R < α|X, A = d(X))] ≥ γ} , (14)
which can be interpreted as the average γ-quantile of R under the decision rule d. Correspondingly
M0(d) can be understood as the γ-average CVaR.
According to Proposition 2.1 (d), M0(d) can be regarded as a lower bound of V (d) andQγ(R(d)).
Thus maximizing M0(d) can potentially maximize both V (d) and Qγ(R(d)). Then the optimal IDR
under our proposed robust criterion M0(d) is defined as
d0 ∈ argmaxd M0(d). (15)
The interpretation of the optimal IDR with respect to M0(d) is to select a treatment/decision with
the largest γ-average CVaR. Moreover, if we again use hypographical representation as in (2) and
(7), then we could formulate it as the following constraint optimization problem:
max
d,t∈R
t
subject to sup
α∈R
{
α− 1
γ
E[(α−R(d))+]
}
≥ t.
(16)
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Based on the formulation (16), d0 can be interpreted as the best IDR with the average lower tail of
the outcome being larger than a certain threshold. Besides, based on statement (e) in Proposition
(2.1), the constraint set in (16) implies min{V (d), Qγ(R(d))} ≥ t. Therefore, by using M0(d), the
resulting optimal d0 can control both (1−γ)×100% of the population’s outcomes and the expected
outcome greater than some threshold t.
By a similar derivation as in (3), we have the following proposition.
Proposition 2.2. M0(d) = supα∈R
{
α− 1γE[ I(A=d(X))pi(A|X) (α−R)+]
}
.
The definition of (10) and Proposition (2.2) give us a way to compute the optimal IDR d0 and
α0 jointly via optimizing
(d0, α0) ∈ argmax
α∈R,d
{
α− 1
γ
Ed[(α−R)+]
}
. (17)
2.5 Duality Representation
Note that M0(d) involves a concave maximization with respect to α. Thus it would be useful
to investigate its dual representation by making use of convex duality theory in Rockafellar (1974).
To begin with, we first define the following set:
Vd0 := {V ∈ L1(T ,F1, P d) |Ed[V ] = 1, 0 ≤ V (ω) ≤
1
γ
, for almost sure all ω ∈ T }. (18)
We have the following theorem that gives the dual representation of M0(d).
Theorem 2.1. M0(d) = infV ∈Vd0 E
d[V R].
According to the duality representation of M0(d) and its proof in the supplementary material,
we can define a conditional probability measure PV(B) =
∫
B V dP
d for any measurable set B ∈ T ,
where V ∈ Vd1 . Then V = dP
V
dP d
. Define
ζ(u) =
0 if 0 ≤ u ≤ 1γ+∞ otherwise .
Then we can further rewrite Ed[RV ] in M0(d) for V ∈ Vd0 as
Ed[RV ] = Ed[R
dPV
dP d
] +E
[
ζ(
dPV
dP d
)
]
= EX[EPV|X
[R]] +EX
[∫
ζ(
dPV
dP d
)dP d
]
= EPV [R] + Iζ
(
dPV
dP d
)
,
where Iζ(·) can be interpreted as the f -divergence distance between PV and P d. Then M0(d) =
infPVP d EPV [R] + Iζ(
dPV
dP d
), where u  v means that the probability measure u is absolutely
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continuous with respect to the probability measure v. Thus the optimal IDR can also be written
as
d0 ∈ argmaxd
{
inf
PVP d
EPV [R] + Iζ(
dPV
dP d
)
}
,
which can be interpreted as choosing an optimal decision rule in terms of the worst expected
outcome within the f -divergence distance from the original distribution P d.
According to our problem setting, define the density under P d is f0(x)I(d(x) = a)f1(r|x, a).
Since PV  P d, then the density under PV should be v0(x)I(d(x) = a)v(r|x, a) for some conditional
probability density v0(x) and v1(r|x, a). Then we can have v0(x)v1(r|x,a=d(x))f0(x)f1(r|x,a=d(x)) by the chain rule.
Therefore, we can further rewrite M0(d) as
M0(d) = inf
PV
{
EPV [R] |PV  P d, 0 ≤
v0(x)v1(r|x, a = d(x))
f0(x)f1(r|x, a = d(x)) ≤
1
γ
, almost surely
}
. (19)
This gives us a natural link to distributionally robust statistical models that can evaluate a decision
rule under ambiguity. Maximizing M0(d) over the decision rule d is equivalent to identifying an
optimal IDR that is robust to the contamination of both outcome R and covariates X characterized
by a probability constraint set.
3 Statistical Estimation and Optimization
In this section, we discuss the estimation and optimization procedures for Problem (2.2) given
observed data. The optimization in (17) can be rewritten as
max
α∈R,d∈D
E
(α− (α−R)+γ )I(A = d(X))
pi(A|X)
 , (20)
where D is some specified classes of decision rules such as the linear ones.
Consider the binary treatment setting and let d(X) = sign(f(X)). Suppose we observe inde-
pendently and identically distributed data (Xi, Ai, Ri); i = 1, · · · , n. Then we can estimate the
optimal IDR via empirical approximation:
max
α∈R,d∈D
1
n
n∑
i=1
I(Ai = sign(f(Xi)))
pi(Ai|Xi)
(
α− (α−Ri)+
γ
)
. (21)
It is well known that optimization over indicator functions is NP hard. Alternatively, we can replace
the 0-1 loss function by the following smooth truncated loss,
S(u) =

0 if u ≤ −δ
(1 + u/δ)2 if 0 > u ≥ −δ
2− (1− u/δ)2 if δ > u ≥ 0
2 if u > δ,
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and then use a functional margin representation to express I(Ai = sign(f(Xi)) as I(Aif(Xi) > 0)
for each i. The corresponding function plot of S(u) is shown in Figure 2 with δ = 1. From the
plot, we can see that the smooth approximation S(u)2 is very close to the 0-1 loss. The parameter
δ can control the closeness of this approximation. In practice, we can simply choose δ = 1.
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Figure 2: Plot of smooth surrogate loss function with δ = 1
By using the surrogate function, we can estimate the optimal IDR under M0(d) via computing
min
α∈R,f∈H
1
n
n∑
i=1
S(Aif(Xi))
pi(Ai|Xi) (α−
(α−Ri)+
γ
) +
λn
2
||f ||2H, (22)
where ||f ||2H is some convex penalty function on f . For example, if we consider H be a Reproducing
Kernel Hilbert Space (RKHS), then ||f ||2H could be the square of RKHS norm of f . The estimated
IDR is given by dˆ0(X) = sign(fˆ(X)). Note that Problem (22) involves a non-convex and potentially
non-smooth optimization problem. Recent developments in difference-of-convex (DC) optimization
(Pang et al. (2016)) motivate us to use DC programming to efficiently solve this problem. Note
that S(u) can be expressed as a difference of convex differentiable functions: S1(u)− S2(u) where
S1(u) =

0 if u ≤ −δ
(1 + u/δ)2 if −δ < u ≤ 0
2 + 2u/δ − 1 if 0 < u
,
and
S2(u) =

0 if u ≤ 0
(u/δ)2 if 0 < u ≤ δ
2u/δ − 1 if u > δ
.
Define
G(1)(f, α) :=
1
n
n∑
i=1
S(Aif(Xi))
pi(Ai|Xi) (−(α−
(α−Ri)+
γ
)) +
λn
2
||f ||2H, (23)
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and
G
(1)
j (f) =
1
n
n∑
i=1
S(Aif(Xi))
pi(Ai|Xi) (−Rj −
(Rj −Ri)+
γ
). (24)
The following proposition gives us a way to express (22) as a DC function.
Proposition 3.1. The following two optimization problems have the same optimal value, i.e.,
min
α∈R,f∈H
G(1)(f, α) = min
f∈H
{
G˜(1)(f)
}
, (25)
where G˜(1)(f) := min1≤j≤n{G(1)j (f)}+ λ2 ||f ||2H. More importantly, the optimal solution sets of f to
both problems are the same.
Proof. Note that for any given f , G(1)(f, α) is a convex piecewise affine function with respect to α.
Thus the optimal solution set α∗ should contain one of the knots, i.e., R1, · · · , Rn. Then it follows
that
min
α∈R
G(1)(f, α) = min
j∈{1,··· ,n}
G
(1)
j (f) +
λn
2
||f ||2H.
Thus
min
f∈H,α∈R
G(1)(f, α) = min
f∈H
{
min
1≤j≤n
{G(1)j (f)}+
λ
2
||f ||2H
}
,
and correspondingly
argminf∈HG1(f, α) = argminf∈H
{
min
1≤j≤n
{Gj(f)}+ λ
2
||f ||2H
}
.
Based on Proposition 3.1, instead of solving (22), we can equivalently solve the optimization
problem in the right hand side of (25). Let cij =
−(Rj− (Rj−Ri)+γ )
pi(Ai|Xi) for i = 1, · · · , n and j = 1, · · · , n,
and note that cij is not necessarily nonnegative. Recall that S(u) = S1(u) − S2(u). Then we can
further rewrite G
(1)
j (f) as
G
(1)
j (f) =
1
n
n∑
i=1
(max(cij , 0)S1(Aif(Xi)) + max(−cij , 0)S2(Aif(Xi)))
− 1
n
n∑
i=1
(max(cij , 0)S2(Aif(Xi)) + max(−cij , 0)S1(Aif(Xi)))
:= Fj(f)−Hj(f),
(26)
where both Fj(f) and Hj(f) are convex functions with respect to f for j = 1, · · · , n. Then we can
further decompose
G˜(1)(f) = min
1≤j≤n
{Fj(f)−Hj(f)}+ λ
2
||f ||2H
=
n∑
i=1
Fj(f)− max
1≤j≤n
{Hj(f) +
n∑
k 6=j
Fk(f)}+ λ
2
||f ||2H
:=F (f)− max
1≤j≤n
hj(f) +
λ
2
||f ||2H,
(27)
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as a DC function, where hj(f) := Hj(f) +
∑n
k 6=j Fk(f). Note that G˜
(1)(f) is a potentially non-
smooth function if there exits multiple k’s such that hk(f) = max1≤j≤n hj(f). As pointed by Pang
et al. (2016), traditional DC programming may potentially converge to nonsense points. Motivated
by Pang et al. (2016), we defineM(f) := {j | hj(f) ≥ max1≤k≤n hk(f)−}, i.e., “-argmax” index
set and use the following enhanced probabilistic DCA summarized in Table 1 below.
Algorithm 1 Algorithm for (22)
1: Given a fixed  > 0, let f (v) be the solution at the v iteration.
2: Randomly select j ∈M(f (v)), and compute
f (v+1) ∈ argminf∈H{F (f)−
∂hj(f
(v))
∂f
(f − f (v)) + λ
2
||f ||2H}. (28)
3: The algorithm stops when |G˜(1)(f (v)) − G˜(1)(f (v+1))| < κ, for some pre-specified positive con-
stant κ.
The proof of convergence to sharp stationary points by the above algorithm can be found
in Pang et al. (2016). For the computation of the subproblem (28), efficient algorithms such as
quasi-newton methods can be used.
4 Analysis of Statistical Convergence
In this section, we discuss the statistical theory related to our estimation under M0(d). We first
define
M0(d, α) = E
[
I(A = d(X))
pi(A|X) (α−
1
γ
(α−R)+)
]
, (29)
and denote the optimal solutions of maximizing (29) as d0 = sign(f0) and α0. Since we use the
surrogate loss function S(u), we further define
MS(f, α) = E
[
S(Af(X))
pi(A|X) (α−
1
γ
(α−R)+)
]
as the surrogate value function. Our theoretical results are based on regret analysis similar to Zhou
et al. (2017).
4.1 Fisher Consistency
We first establish Fisher consistency of estimating optimal ITRs under MS(f, α) to justify the
use of the surrogate loss S(u), compared with M0(d, α). The proof is different from the classical
Fisher consistency in classification, which only involves one functional class of interest. Here we
need to consider the effect of the surrogate function on estimating α.
Theorem 4.1. For any measurable function f and α, if (f∗S , α
∗
S) maximizes MS(f, α), then (sign(f
∗
S), α
∗
S)
maximizes M0(d, α).
Based on Theorem 4.1, instead of M0(d, α), we can target on MS(d, α) equivalently.
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4.2 Excess Value Bound
Based on Theorem 4.1, we can further justify the use of the surrogate function S(u) by estab-
lishing the following excess value bound for the 0-1 loss in M0(d, α).
Theorem 4.2. For any measurable function f, α and any probability distribution over (X, A,R),
M0(d0, α0)−M0(sign(f), α) ≤MS(f∗S , α∗S)−MS(f, α).
Theorem 4.2 gives us a way of bounding the difference between the optimal IDR and the
estimated IDR under M0(d, α) by using MS(d, α) instead.
4.3 Convergence Rate
In order to obtain the finite sample performance of our estimated optimal IDR under M0(d, α),
it is enough to focus on the difference of MS(d, α) between the estimated optimal IDR and the
optimal ITR based on Theorem 4.2. Define
(fˆ , αˆ) = argminf∈H,α∈ROn(f, α) +
λn
2
||f ||2H, (30)
where On(f, α) :=
1
n
∑n
i=1
S(Aif(Xi))
pi(Ai|Xi) (
(α−Ri)+
γ −α). For simplicity, in the following we consider H be
RKHS with Gaussian radial basis functions. The results can be extended to other scenarios such as
the class of linear functions with the l1 penalty. Define OS(f, α) = −MS(f, α) and let (fλn , αλn) =
argminf∈H,α∈ROS(f, α) +
λn
2 ||f ||2H. Then A(λn) := OS(fλn , αλ2n) + λn2 ||fλn ||2H−OS(f∗S , α∗S) is con-
sidered to be the approximation error. The following theorem gives us a finite sample upper bound
of our estimated optimal IDR and the optimal IDR based on M0(d, α).
Theorem 4.3. For any distribution P over (X, A,R) such that |R| ≤ C0, if A(λn) ≤ C1λw1n , where
w1 ∈ (0, 1], then with probability at least 1− ,
M0(d0, α0)−M0(sign(fˆ), αˆ) ≤ C2n−
w1
2w1+1 ,
for some constant C2.
The above theorem shows that the difference between our estimated IDR and the optimal IDR
under M0(d, α) converges to 0 in probability under some conditions. The upper bound assumption
on the approximation error A(λn) is analogous to those in the statistical learning literature such
as Steinwart and Scovel (2007) to derive the convergence rate. The convergence rate is the same
as those in Zhao et al. (2012) and Zhou et al. (2017). This is not surprising because the proposed
M0(d) can be roughly regarded as the truncated mean.
5 Numerical Studies
5.1 Simulation Studies
For all simulation settings, we consider binary-armed randomized trials with equal probabilities
of patients being assigned to each treatment group. We use l1-DC-CVaR, l2-DC-CVaR and GK-
DC-CVaR to represent the methods of estimating optimal IDRs under M0(d) with three different
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penalties on f in Problem (22) respectively. Here “l1” and “l2” refer to the l1 and l2 penalties.
“GK” represents using Gaussian radial basis functions with bandwidth ς to learn the optimal IDR.
In all our numerical studies, we set γ = 0.5.
All tuning parameters are selected based on the 10-fold-cross-validation procedure. We select
the tuning parameter that maximizes the empirical average of M0(d) on the validation data set.
We compare our methods with the following three methods:
(1) l1-PLS by Qian and Murphy (2011) with basis function (1,X, A,XA);
(2) RWL by Zhou et al. (2017) with linear kernel;
(3) RWL by Zhou et al. (2017) with Gaussian kernel.
Since we only consider the randomized design study, we do not compare those methods designed
for observational studies such as Zhang et al. (2012).
5.1.1 A Motivating Example Revisit
Recall the motivating example in Figure 1 that shows the importance of risk controls in estimat-
ing optimal IDRs. In this subsection, we conduct some numerical analysis to further demonstrate
this finding. In particular, the covariate of gender is generated by uniform distribution over {1,−1},
where 1 and −1 denotes male and female respectively. The corresponding outcome R is generated
by the following model:
R = I(XA = 1)1 + I(XA = −1)2,
where 1 ∼ N (−0.1, 1) and 2 ∼ N (0, 0.5). We consider training data with the sample size n = 200
and independently generated test data of size 10000. Based on test data, in Figure 3, we plot box
plots of three different outcome distributions if treatments follow estimated IDRs by l1-PLS, linear
RWL, and l2-DC-CVaR respectively. Based on these box plots, we can observe that since there is
not much difference between these two treatments based on the expected outcome, the empirical
mean of value functions resulted from these three methods are indistinguishable. However, besides
maximizing the expected outcome for each individual, our methods also control the tails of subjects.
The resulting outcome distribution by our method is more stable, and thus has less variability than
those of l1-PLS and linear RWL.
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Figure 3: Box plots of value functions computed by three methods and two reference distributions.
The left box plot corresponds to the result of l1-PLS under the value function framework. The
second box plot corresponds to those of RWL. The middle two box plots correspond to the result
of our proposed method. The last two box plots correspond to two reference normal distributions.
5.1.2 Distribution Shift Examples
In this section, we demonstrate the superior performance of our methods under distribution
shift of both covariates X and outcome R based on the duality representations of M0(d) in (19).
We consider the sample size n = 200 and the dimension p = 20. The outcome R is generated by
the model: R = 1 + x1 + x2 +A(x1− x2 + x3) + . We consider the following two distribution shift
scenarios:
(1) Each covariate follows a two component Gaussian mixture distribution of N (0, 1) and asym-
metric log-normal distribution lognorm(0, 2) with probabilities of the two mixture component
to be 0.7 and 0.3 respectively and  follows the standard Gaussian distribution;
(2) Covariates X are generated by the uniform distribution between −1 and 1 and  follows
a two-component mixture distribution of N (0, 1) and asymmetric log-normal distribution
lognorm(0, 2) with probabilities of the two mixture component to be 0.7 and 0.3 respectively.
The first scenario considers the covariate distribution shift and the second scenario considers the
outcome distribution shift. For simplicity, we only report misclassification error rates given by
l1-PLS, linear RWL and l2-DC-CVaR in Table 1. For Scenario (1), since l1-PLS assumes a linear
model, its performance is not affected by the distributional shift of covariates. In contrast, RWL,
which is based on maximizing the value function, depends heavily on correct approximations to
the value function empirically. Thus the performance of RWL is worse than l1-PLS under this
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scenario. For the estimated optimal IDR under our proposed M0(d), the performance is superior to
RWL because M0(d) considers the perturbation of the covariate distributional shift. For Scenario
(2), since the estimated optimal IDR under M0(d) is a minimax estimator under the outcome
distributional shift, the performances are much better than the other two methods developed under
the value function framework.
Table 1: Comparisons of misclassification error rates (standard errors) for simulated examples with
n = 200 and p = 20.
Scenario (1) Scenario (2)
l1-PLS 0.07 (0.01) 0.41 (0.007)
l2-RWL 0.14 (0.006) 0.40 (0.008)
l2-DC-CVaR 0.08 (0.01) 0.19 (0.004)
5.1.3 Additional Simulation Scenarios
In this subsection, we further study the performance of our proposed methods via eight sim-
ulation examples. In order to have more flexibility, we consider to use M1(d) defined below by
combining our proposed M0(d) and V (d) together:
M1(d) := 0.5V (d) + 0.5M0(d). (31)
The corresponding optimal IDR is denoted by d1. All our results in Sections 3 and 4 can be
naturally extended. In particular, since the surrogate function we use in Section 3 is a DC function,
a small modification can be incorporated in Algorithm 1 to estimate d1 empirically. Moreover, by
making use of the existing results in the literature of expected value function such as Zhou et al.
(2017), we can perform the similar regret analysis for M1(d) as that of M0(d) in Section 4. We
consider the sample size n = 200 and the dimension p = 20. The covariates X are generated
by the uniform distribution between −1 and 1. The outcome R is generated by the model: R =
1 + x1 + x2 +Aδ(X) + . We consider the following eight different combinations of δ(X) and :
(1) δ(X) = x1 − x2 + x3, and  follows Gaussian normal N (0, 4);
(2) δ(X) = x1 − x2 + x3, and log() follows Gaussian normal N (0, 2|1 + x1 + x2|);
(3) δ(X) = x1 − x2 + x3, and log() follows Gaussian normal N (0, 2);
(4) δ(X) = x1−x2 +x3, and  follows a Weibull distribution with shape parameter 0.3 and scale
parameter 0.5;
(5) δ(X) = 3.8(0.8− x21 − x22), and  follows Gaussian normal N (0, 4);
(6) δ(X) = 3.8(0.8− x21 − x22), and log() follows Gaussian normal N (0, 2|1 + x1 + x2|);
(7) δ(X) = 3.8(0.8− x21 − x22), and log() follows Gaussian normal N (0, 2);
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(8) δ(X) = 3.8(0.8− x21− x22), and  follows a Weibull distribution with shape parameter 0.3 and
scale parameter 0.5.
We consider different shapes of error distributions to test the robustness of our methods, compared
with other methods. The first four scenarios are of linear decision boundaries while the remaining
four consider nonlinear decision boundaries. In order to evaluate different methods, we generate
test data and use sign(δ(X)) as the true optimal decision rule, since treatment A only appears in
the interaction term δ(X). We evaluate different methods based on the misclassification error rates
in Table 2, mean of value functions in Table 3, mean of 50% and 25% quantiles of value functions
in Tables 4 and 5 respectively. Overall, our methods show competitive performances among all
methods. In particular, for Scenarios (1) and (5), which are standard simulation settings in the
literature, our proposed methods performs well in finding optimal IDRs. For Scenarios (2) and (6),
the error distributions depend on the covariate information. Although the averages of empirical
value functions of our proposed methods are smaller than those of RWL, the 50% and 25% quantiles
of empirical value functions by our methods are much better. One possible reason is that methods
under the value function framework ignore subjects with potentially high risks while only focusing
on maximizing the value function. Thus the resulting IDRs by these methods may assign wrong
treatments to patients and make them become even worse by delivering the corresponding IDR.
Similar observations can be drawn from other simulation scenarios.
Table 2: Comparisons of misclassification error rates (standard deviations) for simulated examples
with n = 200 and p = 20. From left to right, each column represents Scenarios (1)-(8) respectively.
Each row represents one specific method. The last six rows correspond to our proposed methods.
1 2 3 4 5 6 7 8
l1-PLS 0.28(0.06) 0.5(0.06) 0.44(0.09) 0.45(0.08) 0.44(0.05) 0.52(0.04) 0.5(0.03) 0.49(0.04)
RWL 0.34(0.07) 0.5(0.07) 0.44(0.07) 0.44(0.07) 0.41(0.06) 0.51(0.05) 0.47(0.07) 0.46(0.08)
RWL-GK 0.5(0.01) 0.5(0.01) 0.5(0.01) 0.5(0.01) 0.38(0.05) 0.52(0.12) 0.46(0.12) 0.43(0.11)
l2-DC-CVaR 0.32(0.06) 0.17(0.07) 0.22(0.07) 0.13(0.08) 0.43(0.04) 0.5(0.02) 0.48(0.03) 0.46(0.04)
l1-DC-CVaR 0.32(0.06) 0.16(0.06) 0.19(0.06) 0.1(0.05) 0.44(0.04) 0.5(0.01) 0.49(0.02) 0.49(0.01)
GK-DC-CVaR 0.49(0.02) 0.5(0.01) 0.5(0.01) 0.5(0.01) 0.38(0.03) 0.51(0.12) 0.41(0.09) 0.38(0.05)
Table 3: Comparisons of average value functions (standard deviations) for simulated examples with
n = 200 and p = 20. From left to right, each column represents scenarios (1)-(8) respectively. Each
row represents one specific method. The last six rows correspond to our proposed methods.
1 2 3 4 5 6 7 8
l1-PLS 1.51(0.12) 205839.37(2090994.07) 8.55(0.84) 5.67(0.35) 1.25(0.22) 32480.58(287116.51) 8.42(0.77) 5.68(0.35)
RWL 1.39(0.17) 47681.35(412574.85) 8.58(0.8) 5.7(0.34) 1.37(0.23) 4248.93(13197.34) 8.46(0.87) 5.83(0.47)
RWL-GK 1.01(0.07) 241196.97(2122609.28) 8.41(0.71) 5.55(0.33) 1.47(0.21) 30912.36(279385.21) 8.53(0.94) 5.96(0.54)
l2-DC-CVaR 1.44(0.13) 240599.77(2128310.24) 8.96(0.68) 6.27(0.34) 1.26(0.18) 32777.67(284170.74) 8.53(1.05) 5.78(0.39)
l1-DC-CVaR 1.44(0.13) 240226.39(2128134.97) 8.94(0.61) 6.32(0.33) 1.27(0.18) 32917.95(284157.15) 8.51(1.05) 5.68(0.35)
GK-DC-CVaR 1.02(0.07) 13046.46(72486.56) 8.4(0.76) 5.54(0.35) 1.49(0.15) 34718.08(282511.23) 8.75(0.86) 6.11(0.41)
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Table 4: Comparisons of 50% quantiles (standard deviations) of value functions for simulated
examples with n = 200 and p = 20. From left to right, each column represents scenarios (1)-(8)
respectively. Each row represents one specific method. The last six rows correspond to our proposed
methods.
1 2 3 4 5 6 7 8
l1-PLS 1.52(0.13) 2.21(0.16) 2.71(0.2) 1.93(0.19) 1.28(0.24) 2.35(0.22) 2.86(0.18) 2.03(0.2)
RWL 1.4(0.17) 2.22(0.19) 2.71(0.16) 1.96(0.16) 1.39(0.25) 2.36(0.27) 2.96(0.36) 2.2(0.44)
RWL-GK 1.01(0.07) 2.22(0.05) 2.59(0.05) 1.81(0.04) 1.5(0.23) 2.25(0.65) 3.01(0.58) 2.32(0.58)
l2-DC-CVaR 1.45(0.14) 2.8(0.08) 3.11(0.09) 2.46(0.08) 1.28(0.19) 2.42(0.14) 2.97(0.16) 2.17(0.22)
l1-DC-CVaR 1.45(0.14) 2.82(0.06) 3.13(0.08) 2.48(0.05) 1.28(0.19) 2.43(0.06) 2.91(0.11) 2.04(0.09)
GK-DC-CVaR 1.01(0.08) 2.22(0.04) 2.59(0.05) 1.81(0.04) 1.53(0.16) 2.33(0.67) 3.24(0.42) 2.56(0.29)
Table 5: Comparisons of 25% quantiles (standard deviations) of value functions for simulated
examples with n = 200 and p = 20. From left to right, each column represents scenarios (1)-(8)
respectively. Each row represents one specific method. The last six rows correspond to our proposed
methods.
1 2 3 4 5 6 7 8
l1-PLS -1.3(0.14) 1.02(0.16) 1.28(0.26) 0.69(0.23) -1.71(0.25) 0.68(0.18) 0.89(0.18) 0.25(0.19)
RWL -1.43(0.19) 1.04(0.19) 1.29(0.21) 0.72(0.2) -1.59(0.27) 0.71(0.22) 1.05(0.41) 0.51(0.45)
RWL-GK -1.82(0.08) 1.02(0.04) 1.12(0.05) 0.53(0.04) -1.47(0.23) 0.72(0.57) 1.2(0.63) 0.71(0.57)
l2-DC-CVaR -1.38(0.15) 1.82(0.12) 1.86(0.14) 1.46(0.13) -1.71(0.2) 0.75(0.11) 1.01(0.2) 0.41(0.25)
l1-DC-CVaR -1.37(0.15) 1.84(0.1) 1.9(0.12) 1.5(0.07) -1.7(0.2) 0.75(0.05) 0.93(0.13) 0.25(0.09)
GK-DC-CVaR -1.82(0.08) 1.03(0.03) 1.12(0.05) 0.53(0.04) -1.45(0.17) 0.79(0.6) 1.46(0.46) 0.95(0.28)
5.2 Real Data Applications
In this section, we perform a real data analysis to further evaluate our proposed robust criterion
for estimating optimal IDRs. We use the clinical trial dataset from “AIDS Clinical Trials Group
(ACTG) 175” in Hammer et al. (1996) to study whether there exists some subpopulations that are
suitable for different combinations of treatments for AIDS. In this study, a total number of 2139
patients with HIV infection is randomly assigned into four treatment groups: zidovudine (ZDV)
monotherapy, ZDV combined with didanosine (ddI), ZDV combined with zalcitabine (ZAL), and
ddI monotherapy with equal probability. In this data application, we focus on finding optimal IDRs
between two treatments: ZDV with ddI and ZDV with ZAL as our interest. The total number of
patients receiving these two treatments are 1046.
Similar to the previous studies by Lu et al. (2013) and Fan et al. (2017), we select 12 base-
line covariates for our model: age (year), weight(kg), CD4 T cells amount at baseline, Karnofsky
score (scale at 0-100), CD8 amount at baseline,gender (1 = male, 0 = female), homosexual ac-
tivity (1 = yes, 0 = no), race (1 = non white, 0 = white), history of intravenous drug use (1
= yes, 0 = no), symptomatic status (1=symptomatic, 0=asymptomatic), antiretroviral history
(1=experienced, 0=naive) and hemophilia (1=yes, 0=no). The first five covariates are continuous
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and have been scaled before estimation. The remaining seven covariates are binary categorical
variables. We consider the outcome as the early stage (around 25 weeks) CD4+ T (cells/mm3) cell
amount. Using this outcome, we can estimate the optimal IDR under our proposed robust criterion.
To evaluate the performance of our proposed methods under robust criterion, we randomly divide
the dataset into five folds and use four of them to estimate optimal IDRs by different methods.
The remaining one fold of data is used to evaluate the performances of different methods. We
repeat this procedure 200 times. For each method, we report the mean, 25% and 10% quantiles
of empirical value functions. From Table 6, we can see that our proposed methods perform best
among all methods. Furthermore, our method is also the best in terms of means of the empirical
value functions due to the heavy right tail distribution of R as shown in Figure 4. This is consistent
with our findings in the simulation settings when the outcome distribution has potential heavy right
tails. In terms of 25% and 10% quantiles of empirical value functions, we can see the advantages
of our method are more significant than the other two as we focus more on the tails of outcomes
for each individual.
Table 6: Results of value function comparison for the AIDS data. First column represents the
means of empirical value functions. Second and third columns represent means of 50% and 25%
quantiles of empirical value functions, respectively.
Vn(d) 25% quantiles 10% quantiles
l1-PLS 401.11(0.06) 285.98(0.07) 216.03(0.09)
rwl 400.77(0.06) 285.44(0.07) 215.66(0.08)
l2-DC-CVaR 401.71(0.06) 287.28(0.07) 217.01(0.09)
Outcome R
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Figure 4: Histogram of the early stage CD4+ T cell amount. It exhibits a heavy right tail behavior.
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6 Extensions
In this paper, we propose a robust criterion to estimate optimal IDRs by considering individ-
ualized risk using the concept of CVaR. The resulting optimal IDRs can not only improve the
individualized expected outcome, but also prevent adverse consequences by controlling the lower
tails of the outcome. In this section, we discuss several extensions of our proposed criterion on the
perspective of both the modeling and the algorithm.
6.1 Control of Individualized Lower Tails
One interesting question is whether we can control the individualized γ-CVaR instead of average
γ-CVaR of the outcome for each subject. In this subsection, we discuss another criterion as an
extension of M0(d) in (10) from the average level risk control to the individualized level. Basically,
we define the decision-based individualized CVaR function as follows:
M2(d) := sup
α∈L1(X ,Ξ,PX)
{
E[α(X)]− 1
γ
E[(α(X)−R(d))+]
}
= sup
α∈L1(X ,Ξ,PX)
{
Ed[α(X)− 1
γ
(α(X)−R)+]
}
,
(32)
where Ξ is the σ-field generated by X and PX is the corresponding probability measure. In order
to understand M2(d), we need to characterize the optimal α
∗ in (32) given any IDR d. Define the
individualized γ-quantile as Qγ(R|X = x,A = a) := inf{α : P (R < α(x, a)|X = x,A = a) ≥
1− γ} and individualized γ-CVaR as CVaRγ(R|X, a) := sups∈R{s− 1γE[(s−R)+|X, A = a]} given
covariates X and A = a. The following theorem gives an explicit expression of the optimal α∗ by
using the theory of variational analysis (Rockafellar and Wets (2009)).
Theorem 6.1. Given any decision rule d, α∗ is optimal to the optimization problem in M2(d) if
and only if
α∗(X) = Qγ(R|X, A = d(X)) almost surely. (33)
Thus
M2(d) = E[CVaRγ(R|X, A = d(X))]. (34)
According to (33), the explicit form of α∗(X) in M2(d) can be interpreted as the individual
γ-quantile by the decision rule d. Then M2(d) in (34) takes each individualized CVaR into consid-
eration. The following proposition explains the relationships of M2(d) to M0(d) and V (d).
Proposition 6.1. The following two inequalities hold: M0(d) ≤M2(d) ≤ V (d).
Proof. The first inequality follows the fact that any constant is an element of L1(X ,Ξ, PX). The
second inequality is similar to (d) in Proposition 2.1.
The first inequality in Proposition 6.1 indicates that M2(d) improves M1(d) by extending α to
incorporate the covariates information X. The second inequality in Proposition 6.1 justifies the
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conservativeness of M2(d) as a lower bound of V (d), which can also provide the risk control. In
addition, since CVaRγ(R|X, a) ≤ Qγ(R|X, a), one can have M2(d) ≤ E[Qγ(R|X, d(X))]. Then the
optimal IDR under M2(d) is defined as
d2 ∈ argmaxdM2(d). (35)
Based on Theorem 6.1, we have the explicit expression for d2 by the following proposition.
Proposition 6.2. The optimal IDR under the criterion M2(d) is given by
d2(X) ∈ argmaxa∈A {CVaRγ(R|X, a)} almost surely.
Thus, under M2(d), the optimal IDR d2 is equivalent to choosing a treatment that has the largest
individualized γ-CVaR among all treatments. By a similar derivation, we can also express M2(d)
in a dual form. Define
Wd2 := {W ∈ L1(T ,F1, P d) | 0 ≤W (ω2) ≤
1
γ
for almost sure ω2 ∈ T , E[W |X, A = d(X)] = 1}.
(36)
We have the following theorem that gives the dual representation of M2(d).
Theorem 6.2. M2(d) = infW∈Wd2 E
d[WR].
Duality representation of M2(d): Similarly, for W ∈ Wd2 , if we define PW|X (B) =
∫
BWdP
d
|X
for any measurable set B ∈ T , then W = dP
W
|X
dP d|X
. Thus the optimal IDR can also be written as
d2 ∈ argmaxd
{
inf
PW|XP d|X
EPW [R] +EXIζ(
dPW|X
dP dX
)
}
,
where Iζ(
dPW|Xb
dP d|X
) = Ed|X
[
ζ(dP
V
dP d
)
]
. Moreover, the conditional probability density W with respect to
P d given X can be written as v1(r|x,a=d(x))f1(r|x,a=d(x)) by the chain rule, according to our problem setting.
Therefore, we can also express M2(d) as
M2(d) = inf
PW
{
EPW [R] |PW|X  P d|X, 0 ≤
w(r|x, a = d(x))
f1(r|x, a = d(x)) ≤
1
γ
, almost surely
}
. (37)
Maximizing M2(d) over the decision rule d is equivalent to identifying an optimal IDR that is robust
to the contamination of the outcome R.
Comparisons between M0(d) and M2(d): From a duality representation perspective, we can
see M0(d) and M2(d) have substantial differences with regard to their robustness. The “minimax”
sense of M0(d) in (19) considers the scenario where both distributions of the covariates X and
outcome R are perturbed from true underlying distributions. For M2(d), Proposition 6.1 shows
that M2(d) ≥ M1(d), which means considering individualized CVaR improves the outcome of a
given decision rule d. At the same time, however, it also indicates M2(d) is not as conservative
as M0(d). This can also be justified by the “minimax” representation of (37), which considers the
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contamination of outcome R. In the end, both M0(d) and M2(d) are more robust than the value
framework, i.e., V (d). ThereforeM0(d) andM2(d) may have better ability to improve generalization
by quantifying the inconsistency between training and test data.
Similar to (17), theoretically we can compute α2(X) and d2 jointly via
(d2, α2(X)) ∈ argmax
d, α∈L1(X ,Ξ,PX)
{
E[α(X)]− 1
γ
Ed[(α(X)−R)+]
}
. (38)
Although given the data we could use empirical approximation to compute d2 and α2(X) by as-
suming them belong to some functional classes, the estimation of model-dependent α2(X) is chal-
lenging. Simply restricting α2(X) to be some smooth functions may lead to potentially model
mis-specifications. According to the explicit form of α∗(X) in Theorem 6.1, the true α2(X) may
be a non-smooth function of X. For example, if the individualized γ-quantile Qγ(R|X, A) is linear
in both X and A, then in most cases α∗(X) will be a non-smooth function of X. Thus it would
be desirable to explore a broader structure of α(X) or develop some robust estimation methods to
overcome potential model misspecifications of α2(X).
6.2 Flexible Models
In the previous real data application, we include the expected value function V (d) with the
proposed M0(d) in (31) to allow more flexibility to find the best IDRs. This is roughly equivalent
to maximizing V (d) among all the decision rules with M0(d) being larger than some threshold.
Such an interpretation motivates us an approach to find the optimal IDR when observing multiple
outcomes after receiving treatments. Without loss of generality, suppose we can observe a risk
outcome H in addition to R. In general, we prefer a smaller risk outcome. By some modification
on M0(d), we can search the optimal IDRs by
max
d∈D
V (d)
subject to min
α∈R
{
α+
1
γ
E[(H(d)− α)+]
}
≤ t,
(39)
for some pre-specified constant t, so that we can control the risk outcome with the CVaR criterion.
By a similar analysis as in Section 2, the resulting IDRs using (39) are the best IDRs among all
the decision rules with the risk outcome of (1− γ)× 100% of the population being less than some
threshold t. Given the data, we could use the same techniques in Section 3 to estimate the IDR.
Specifically, by using a surrogate function S, we can solve the following optimization problem:
max
d∈D
1
n
n∑
i=1
RiS(Aif(Xi))
pi(Ai|Xi) +
λ
2
||f ||2H
subject to min
1≤j≤n
{
1
n
n∑
i=1
(Rj +
1
γ (Ri −Rj)+)S(Aif(Xi))
pi(Ai|Xi)
}
≤ t,
(40)
which again can be formulated as optimizing a DC function with a DC constraint as we can see
the minimum of a finite number of DC functions in the constraint is a DC function. However,
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several issues need to be solved before proceeding. The existence of the optimal solution for the
optimization problem (40) should be demonstrated. The use of a surrogate function to replace the
indicator function in (39) needs to be justified. Another challenge is to establish regret bounds for
Problem (39). Existing techniques in statistical learning theory cannot be directly used since there
is a stochastic term in the constraint of (39). It will be an interesting direction to pursue.
6.3 Flexible Decision Rules
In practice, decision makers may want to specify the class of decision rules D that can in-
clude problem-specified constraints such as fairness, which was considered in the literature such
as Bhattacharya and Dupas (2012) and Athey and Wager (2017). However, it may be difficult to
incorporate such constraints by using the surrogate function in our estimation. Next we show how
we can get around with this difficulty. We can first rewrite Problem 21 as
max
1≤j≤n
{
max
d∈D
1
n
n∑
i=1
I(Ai = d(X))
pi(Ai|Xi) (Rj −
(Rj −Ri)+
γ
)
}
, (41)
by the piecewise linearity with respect to α in (21). Based on this representation, we can learn
d0 by solving n different weighted classification problems and choose the best one with the largest
objective value. Based on the pre-specified D, for each weighted classification problem, we could
implement the corresponding machine learning algorithm such as decision trees. However, it raises
some computational concerns by using this algorithm since we need to solve n subproblems, es-
pecially when n is large. Here we provide a heuristic algorithm by iteratively solving α and d for
Problem (41) as shown in Table 2 to obtain dˆ and αˆ.
Algorithm 2 Algorithm for (41)
1: Initial α(0) be any number in {R1, · · · , Rn}.
2: For the (k + 1) iteration, given the last α(k), compute d(k) via
max
d∈D
1
n
n∑
i=1
I(Ai = d(X))
pi(Ai|Xi) (α
(k) − (α
(k) −Ri)+
γ
), (42)
using any machine learning algorithm.
3: Given d(k), obtain α(k+1) by solving
max
α
1
n
n∑
i=1
I(Ai = d(k)(X))
pi(Ai|Xi) (α−
(α−Ri)+
γ
). (43)
4: The algorithm stops when α(k) = α(k+1).
Based on Problem (41), we establish the corresponding regret bound with respect to (dˆ, αˆ).
Denote (d∗, α∗) ∈ argmaxd∈D,α∈RM0(d, α) and Mn(d, α) as an empirical approximation of M0(d, α).
We also define the Vapnik-Chervonenkis dimension of D as VC(D). Then we have the following
theorem.
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Theorem 6.3. Given R is uniformly bounded by C0, then for any  > 0, with probability at least
1− ,
M0(d
∗, α∗)−M0(dˆ, αˆ) ≤ c1
√
VC(D)
n
, (44)
with some constant c1 that depends on C0, γ, c and . In particular,
M0(d
∗, α∗)−E[M0(dˆ, αˆ)] ≤ c2
√
VC(D)
n
(45)
for some constant c2.
While the result is the similar to that in Kitagawa and Tetenov (2018), the proof is much more
involved because we need to deal with α and d together.
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